Article
Surgeon explains importance of achieving high-quality wavefront map first
4DMT refocuses pipeline to prioritize 4D-150 trials in wet AMD and DME
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Formycon partners with Teva, Klinge Biopharma for commercialization of aflibercept biosimilar FYB203 (AHZANTIVE)
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Multiple companies appoint new leadership across the industry
Study reveals link between hypoxia and nAMD